Alerts will be sent to your verified email
Verify Email
CURIS
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Curis Lifesciences is engaged in the pharma manufacturing. It specializes in manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, Oral Liquid, etc. It undertakes manufacturing activities on loan license, Contract Manufacturing and Direct Export basis/Own Brand Marketing basis. It operates in global as well as domestic markets.
Curis Lifesciences major competitors are Sotac Pharmaceutical, Lincoln Pharma.
Market Cap of Curis Lifesciences is ₹0 Crs.
While the median market cap of its peers are ₹598 Crs.
Curis Lifesciences seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | ||||||||||||||||||
| Investor Presentation | ||||||||||||||||||
| Conference Call | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
